WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Monday, March 27, 2017 
Add Press Release News | News Feeds Feeds | Email This News Email

Drug-Eluting Stents Market 2015-2022 - Global Strategic Business Report 2017 - High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents - Research and Markets
Friday, February 17, 2017

DUBLIN, Feb 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Drug-Eluting Stents - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million.

The report profiles 35 companies including many key and niche players such as

    --  Abbott Laboratories (US)
    --  AlviMedica (Turkey)
    --  Arterius Limited (UK)
    --  B. Braun Melsungen AG (Germany)
    --  Biosensors International Group, Ltd. (Singapore)
    --  Shandong JW Medical Systems LTD. (China)
    --  Biotronik SE & Co. KG (Germany)
    --  Boston Scientific Corporation (US)
    --  Cook Medical Inc. (US)
    --  Elixir Medical Corp. (US)
    --  KYOTO MEDICAL PLANNING Co., Ltd. (Japan)
    --  Lepu Medical Technology (Beijing) Co., Ltd. (China)
    --  Medtronic plc (Republic of Ireland)
    --  Micell Technologies, Inc. (US)
    --  Opto Circuits (India) Ltd (India)
    --  Eurocor GmbH (Germany)
    --  OrbusNeich Medical Company Limited (Hong Kong)
    --  QualiMed (Germany)
    --  Shanghai MicroPort Medical (Group) Co., Ltd. (China)
    --  Sino Medical Sciences Technology Inc. (China)
    --  STENTYS SA (France)
    --  Terumo Corporation (Japan)

Key Topics Covered:

1. Industry Overview

2. Macro Growth Drivers

    --  Aging - A Key Market Driver
    --  Global Aging Population Demographic Statistics: Key Opportunity
    --  High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and

3. Coronary Stenting - An Insight

    1. Cardiovascular Diseases - A Brief Description
    2. Coronary Heart Disease
    3. Treatment Options for Coronary Artery Disease
    4. Percutaneous Transluminal Coronary Angioplasty (PTCA)
    5. Coronary Artery Bypass Graft (CABG)
    6. Coronary Stenting
    7. How is Coronary Stenting Performed - Procedure
    8. Risks and Problems Associated with Placing a Stent
    9. Restenosis - A Major Challenge
    10. Cost and Price Economics of DES
    11. Cost Evaluation of DES
    12. Impact of DES on Indirect Costs

4. Product Launches & Approvals

    --  MicroPort Medical Receives Marketing Approval in Argentina for
        Firehawk® DES
    --  MicroPort Medical's Firehawk® DES Receives Marketing Approval in Brazil
    --  Biotronik Launches Biostem Clinical Trial for Orsiro Hybrid DES
    --  Boston Scientific's Eluvia DES System Receives CE Mark
    --  STENTYS Enters into Commercialization Agreements in Europe for
        below-the-knee arterial DES
    --  Medtronic Launches Expanded Sizes of Onyx DES and Expands Indications
    --  Svelte Medical Launches SLENDER Coronary Stent System in Europe
    --  Boston Scientific Receives FDA Approval for SYNERGY DES System
    --  Medtronic Launches Resolute Onyx DES in India

5. Recent Industry Activity

    --  Cordis Enters into Coronary Stent Sales Agreement with Biosensors
    --  MicroPort Scientific Acquires DES Assets and Intellectual Property from

6. Focus On Select Global Players

7. Global Market Perspective

Total Companies Profiled: 35 (including Divisions/Subsidiaries - 40)

- The United States (16)

- Japan (2)

- Europe (20)

- France (1)

- Germany (4)

- The United Kingdom (2)

- Rest of Europe (3)

- Asia-Pacific (Excluding Japan) (10)

- Middle East (1)

- Africa (1)

For more information about this report visit

Media Contact:

Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Systemax Further Streamlines Operations To Increase Focus On Its Profitable North American Industrial Products And France IT Businesses | Mar 27, 2017
Nav Renowned Drone Photographer Elia Locardi Partners With DJI To Host Aerial Photography Workshop World Tour | Mar 27, 2017
Nav ICIS Enhances European Gas Benchmarks with Launch of US Dollar Contracts | Mar 27, 2017
Nav Billboards Aim to Reduce Vehicle Theft Rate in Albuquerque Area | Mar 27, 2017
Nav A new project for Quebec entrepreneur Olivier Primeau will mark the first Canadian collaboration by JACK & JONES | Mar 27, 2017
Nav APrivacy Introduces Lamivoie Capital Partners as a New Client | Mar 26, 2017
Nav As First Utility Hike Rates 9.7%, Invites Affected to Switch Providers | Mar 26, 2017
Nav Internet Marketing Company, fishbat, Shares 5 Ways to Improve Business Websites for Modern Interaction | Mar 25, 2017
Nav Salesforce Named a Leader in B2C Commerce Suites by Independent Research Firm | Mar 24, 2017
Nav Global Human Embryonic Stem Cell (HESC) Research Report 2014-2017 & 2022 - Research and Markets | Mar 24, 2017

Submit News | View More News View More News